As the four-year review of Section 301 duties continues, the Office of the U.S. Trade Representative (USTR) stated last week that the Biden administration will be extending tariff exclusions through May 31, 2024. These exclusions, listed in the USTR’s index, were set to expire on December 31, 2023, but the administration chose to extend the deadline, allowing the agency to thoroughly complete the “orderly sunsetting” of these exclusions. The agency outlined in its December 26th, 2023 statement that a docket will be opening on January 22nd, 2024, to allow for public comments on whether to extend existing exclusions past May 2024. The commenting period is set to close on February 21st, 2024 at 11:59 p.m. ET.

The new docket will focus on “the availability of products covered by the exclusion from sources outside of China, efforts undertaken to source products covered by the exclusion from the United States or third countries, why additional time is needed, and on what timeline, if any, the sourcing of products covered by exclusion is likely to shift outside of China.”

Following the inception of the Section 301 duties on Chinese goods under the Trump administration, USTR introduced a process allowing importers to apply for exclusion from these duties. Although most of the exclusions have expired, 352 exclusions were reinstated in and extended repeatedly since 2022, when the statutory review of the tariffs began. Additionally, USTR has allowed and extended exclusions for certain medical goods designated as essential in combatting the COVID-19 pandemic, bringing the total number of current exclusions to 429.

The first public comment window, which closed in January 2023 with around 1,500 comments submitted on more than 115 HTS codes, focused on the effectiveness of the Section 301 tariffs to combat unfair trade practices by China as well as how the actions have affected the United States economy, including U.S. workers and consumers.

This delay follows another extension in October 2023, when the office noted that adequate examination under the four-year review necessitated additional time. This most recent extension prolongs the anticipated completion of the review, which U.S. Trade Representative Katherine Tai marked as the fall, per her summer statements. The four-year review process, which was initiated on May 3, 2022, has lasted over a year and a half. However, last week the office declined to comment on a projected end date.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of John Brew John Brew

John Brew is the co-chair of Crowell & Moring’s International Trade Group and a partner in the firm’s Washington, D.C. office. He has extensive experience in import and export trade regulation, and he regularly advises corporations, trade associations, foreign governments, and non-governmental organizations…

John Brew is the co-chair of Crowell & Moring’s International Trade Group and a partner in the firm’s Washington, D.C. office. He has extensive experience in import and export trade regulation, and he regularly advises corporations, trade associations, foreign governments, and non-governmental organizations on matters involving customs administration, enforcement, compliance, litigation, legislation and policy.

John represents clients in proceedings at the administrative and judicial levels, as well as before Congress and the international bureaucracies that handle customs and trade matters. He advises clients on all substantive import regulatory issues handled by U.S. Customs and Border Protection and Immigration and Customs Enforcement, such as classification, valuation, origin, marking, tariff preference programs, other agency regulations, admissibility, import restrictions, quotas, drawback, audits, prior disclosures, penalties, investigations, Importer Self Assessment and Customs-Trade Partnership Against Terrorism programs, importations under bond, the Jones Act, vessel repairs, and foreign trade zone matters.

Photo of Emily Devereaux Emily Devereaux

Emily Devereaux is a senior international trade analyst I in Crowell & Moring’s Washington, D.C. office. She provides practice support to the International Trade Group on import regulatory matters pending before the Office of the U.S. Trade Representative (USTR) and U.S. Customs and

Emily Devereaux is a senior international trade analyst I in Crowell & Moring’s Washington, D.C. office. She provides practice support to the International Trade Group on import regulatory matters pending before the Office of the U.S. Trade Representative (USTR) and U.S. Customs and Border Protection (CBP). She works closely with attorneys developing courses of action for clients impacted by investigations under Section 301 of the Trade Act of 1974 and Section 232 of the Trade Expansion Act of 1962. She also supports unfair trade investigations, including antidumping (AD) and countervailing duty (CVD) investigations, sunset reviews, and changed circumstance reviews before the Department of Commerce and the International Trade Commission (ITC).